These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12552793)
61. Very late bare-metal stent thrombosis. A case report and review of the literature. Manjappa N; Agarwal A; Cavusoglu E J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449 [TBL] [Abstract][Full Text] [Related]
62. Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence. Marín F; Kirchhof P; Lip GY Europace; 2009 Jul; 11(7):842-3. PubMed ID: 19546184 [No Abstract] [Full Text] [Related]
63. Release profiles in drug-eluting stents: issues and uncertainties. Venkatraman S; Boey F J Control Release; 2007 Jul; 120(3):149-60. PubMed ID: 17582635 [TBL] [Abstract][Full Text] [Related]
64. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255 [TBL] [Abstract][Full Text] [Related]
65. Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes. Meng M; Liu Y; Wang YB; Wang JC; Zhang H; Wang XQ; Zhang X; Lu WL; Zhang Q J Control Release; 2008 Jun; 128(2):113-9. PubMed ID: 18423766 [TBL] [Abstract][Full Text] [Related]
66. [Late stent thrombosis with drug eluting stents: disturbing signals on the radar]. Hansen PR Ugeskr Laeger; 2007 Apr; 169(17):1561-3. PubMed ID: 17484825 [TBL] [Abstract][Full Text] [Related]
67. Optimal stent design for drug delivery. Rogers CD Rev Cardiovasc Med; 2004; 5 Suppl 2():S9-S15. PubMed ID: 15184829 [TBL] [Abstract][Full Text] [Related]
68. Concerns over safety of drug-eluting stents. Expert Rev Med Devices; 2006 Nov; 3(6):689-90. PubMed ID: 17280532 [No Abstract] [Full Text] [Related]
69. Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force. Hodgson JM; Stone GW; Lincoff AM; Klein L; Walpole H; Bottner R; Weiner BH; Leon MB; Feldman T; Babb J; Dehmer GJ; Catheter Cardiovasc Interv; 2007 Feb; 69(3):327-33. PubMed ID: 17219373 [No Abstract] [Full Text] [Related]
70. Pharmacokinetics of hirudin. Nowak G Semin Thromb Hemost; 1991 Apr; 17(2):145-9. PubMed ID: 1771412 [No Abstract] [Full Text] [Related]
71. Hirudin and excess bleeding. Implications for future use. Zeymer U; Neuhaus KL Drug Saf; 1995 Apr; 12(4):234-9. PubMed ID: 7646821 [No Abstract] [Full Text] [Related]
73. [Further experimental studies on the effect of a hirudin-containing ointment]. Tronnier H Hautarzt; 1969 Mar; 20(3):114-6. PubMed ID: 5355957 [No Abstract] [Full Text] [Related]